bioRxiv/medRxiv TRiP Review Activity

412 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 11: Articles 101-110  | Next

Bestrophin-4 relays Hes4 and interacts with Twist1 to suppress epithelial-to-mesenchymal transition in colorectal cancer cells
Wang, Z., Xia, B., Qi, S., Zhang, X., Zhang, X., Li, Y., Wang, H., Zhang, M., Zhao, Z., Kerr, D., Yang, L., Cai, S., Yang, J.
10.1101/2023.07.03.547525 — Posted: 2023-07-03 — Discussion: 2024-10-02  eLife
High-density sampling reveals volume growth in human tumours
Angaji, A., Owusu, M., Velling, C., Dick, N., Weghorn, D., Berg, J.
10.1101/2023.12.10.570995 — Posted: 2023-12-10 — Discussion: 2024-10-01  eLife
Restraint of melanoma progression by cells in the local skin environment
Ma, Y., Tagore, M., Hunter, M. V., Huang, T.-H., Montal, E., Weiss, J. M., White, R. M.
10.1101/2024.08.15.608067 — Posted: 2024-08-19 — Discussion: 2024-10-01  eLife
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Rincon-Torroella, J., Dal Molin, M., Mog, B., Han, G., Watson, E., Wyhs, N., Ishiyama, S., Ahmedna, T., Minn, I., Azad, N. S., Bettegowda, C., Papadopoulos, N., Kinzler, K. W., Zhou, S., Vogelstein, B., Gabrielson, K. L., Sur, S.
10.1101/2023.07.23.550207 — Posted: 2023-07-25 — Discussion: 2024-09-24  eLife
Super-Enhancer Driven ZFP36L1 Promotes PD-L1 Expression in Infiltrative Gastric Cancer
Wei, X., Liu, J., Zhuo, H., Cheng, J., Cai, W., Xie, W., Wang, K., Lin, L., Hou, J., Cai, J.
10.1101/2024.05.22.595316 — Posted: 2024-05-23 — Discussion: 2024-09-20  eLife
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
Barber, A. G., Quintero, C. M., Hamilton, M., Rajbhandari, N., Sasik, R., Zhang, Y., Kim, C., Husain, H., Sun, X., Reya, T.
10.1101/2024.04.11.589053 — Posted: 2024-04-15 — Discussion: 2024-09-12  eLife
Proteomic analysis reveals microvesicles containing NAMPT as mediators of radiation resistance in glioma
Panizza, E., Regalado, B. D., Wang, F., Nakano, I., Vacanti, N. M., Cerione, R. A., Antonyak, M. A.
10.1101/2022.03.23.485479 — Posted: 2022-03-23 — Discussion: 2024-09-11  EMBO Press
The T Cell Receptor beta Chain Repertoire of Tumor Infiltrating Lymphocytes Improves Neoantigen Prediction and Prioritization
Pham, T. M. Q., Nguyen, T. N., Nguyen, B. Q. T., Nguyen, H. T. P., Tran, T. P. D., Pham, N. M. D., Ho, T. K. C., Nguyen, D. V. L., Nguyen, H. T., Tran, D. H., Tran, T. S., Pham, T.-V. N., Le, M.-T., Nguyen, T. T. V., Phan, M.-D., Giang, H., Nguyen, H.-N., Tran, L. S.
10.1101/2023.11.16.567478 — Posted: 2023-11-17 — Discussion: 2024-09-10  eLife
TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis
Ju, Q., Sheng, W., Zhang, M., Chen, J., Wu, L., Liu, X., Fang, W., Shi, H., Sun, C.
10.1101/2024.03.22.586256 — Posted: 2024-03-27 — Discussion: 2024-09-09  eLife
Generating specific homologous neutralizing-antibodies: a novel therapeutic strategy in cancer treatment
Liu, Z.
10.1101/2023.07.26.550693 — Posted: 2023-07-29 — Discussion: 2024-08-30  eLife

Evaluation Sources